Pemetrexed Injection, Powder, Lyophilized, For Solution
Product Images NDC 70771-1691

This is a medication containing pemetrexed disodium, a cytotoxic agent used for chemotherapy. Each vial contains 100mg and may also contain sodium hydroxide to adjust pH. It should be stored at controlled room temperature and discard any unused portion. The accompanying literature provides guidelines for storage of reconstituted and infusion solutions. This drug is for intravenous use only and is manufactured by Zydus Hospira Oncology Private Limited in India.*

This text describes a medication called Pemetrexed, which is stored in a vial and intended for intravenous use only. Each vial contains 100mg of pemetrexed disodium and 106mg of mannitol USP. The medication must be reconstituted by adding 42mL of 0.9% Sodium Chloride Injection to obtain a solution containing 25 mg/mL pemetrexed. Reconstituted solution must be further diluted before use. The infusion solution should be administered within 24 hours of initial reconstitution. The accompanying literature should be consulted for dosage information. The manufacturer of the medication is Zytus Hospira Oncology Private Limited, located in Ahmedabad, India. The medication should be stored at 25°C with excursions permitted to 15°-30°C. The storage of reconstituted and infusion solutions should occur at refrigerated 2°-8°C.*

This is a description of a drug called R 7V C, which is a cytotoxic agent. Each vial contains pemetrexed disodium, equivalent to 500 mg of pemetrexed, with mannitol USP and either hydrochloric acid NF or sodium hydroxide NE added to adjust pH. It is for intravenous use only and should be stored at 25°C (77°F), with excursions permitted between 15° and 30°C (59° and 86°F). The drug is manufactured by Zydus Hospira Oncology Private Limited in Anmedabad, India. Further information on storage of reconstituted and infusion solutions can be found in the accompanying literature. Unused portions should be discarded.*

This is the description: Pemetrexed is a cytotoxic agent that can be administered through intravenous use only. It comes in a single-dose vial and requires dilution before use. The solution must be infused within 24 hours after initial reconstitution and unused portions should be discarded. Pemetrexed contains pemetrexed disodium equivalent to 500mg, 500mg of mannitol USP, and hydrochloric acid NF and/or sodium hydroxide NF may have been added to adjust the pH. The drug is manufactured by Zydus Hospia Oncology Private Limited, located in Ahmedabad, India. The text provides instructions on how to store the drug and how to properly use it.*

RS VI Cytotoxic Agent is a medication that comes in the form of vials containing pemetrexed disodium, equivalent to 1000mg pemetrexed, mixed with 1000 mg of mannitol USP. pH adjusters like Hydrochloric acid and/or sodium hydroxide may have been added to the vial. The medication is for intravenous use, and any unused portion of the medication should be discarded. The storage instructions state that the vial should be kept at 25°C (77°F) with temporary excursions allowed to 15°-30°C (59°-86°F). It is manufactured by Zydus Hospira Oncology Private Limited, located in Ahmedabad, India. The text is providing information about the medication's ingredients, storage, and usage.*

This is a description of a medicine product with the brand name "Pemetrexed for Injection, USP". It comes in individual single-dose vials with a concentration of 1000 mg/vial and is intended for intravenous use only. The product contains pemetrexed disodium equivalent to 1000 mg and mannitol USP 1000 mg. Sodium chloride injection can be added to make a solution containing 25 mg/mL of pemetrexed, which should be diluted prior to use. Cytotoxic properties are mentioned, and storage recommendations are included. Please refer to the accompanying literature for dosage information. The medicine is manufactured by Zydus Hospira Oncology Pvt. Ltd. in Ahmedabad, India.*